5705 abstracts found.



Results filter

The use of Oncotype Dx in adjuvant chemotherapy decision-making in early breast cancer patients with intermediate risk of mortality at 10 years

Year:

Session type:

Theme:

Anisha Ramessur1,Catherine Harper-Wynne2,Russell Burcombe2,Rema Joythirmayi2
1MAIDSTONE AND TUNBRIDGE WELLS NHS TRUST,2Maidstone and Tunbridge Wells NHS Trust

Gold nanoparticle radiopharmaceuticals for the selective treatment of telomerase-positive tumours

Year:

Session type:

Theme:

Bas Bavelaar1,Lei Song1,Mark Jackson2,Philip Waghorn3,Katherine Vallis1
1University of Oxford,2University of Glasgow,3Harvard University

Fibroblast growth factor receptor 3 (FGFR3) mutant muscle invasive bladder cancers (MIBC) are associated with low immune infiltrates

Year:

Session type:

Theme:

Elaine Kilgour1,Elaine Kilgour1,Helen K. Angell2,Neil R. Smith3,Miika J. Ahdesmaki2,J. Carl Barrett4,Elizabeth A. Harrington2,Carolyn Hurst5,Margaret Knowles5
1AstraZeneca,2AstraZeneca, Cambridge UK,3AstraZeneca, Macclesfield UK,4AstraZeneca, Boston USA,5Institute of Cancer Studies, Leeds UK

BARRETT’S OESOPHAGUS PATIENTS ATTENDING HOSPITAL: BASELINE CLINICAL, PATIENT HISTORY AND QUALITY OF LIFE DATA FROM BOSS AND ASPECT

Year:

Session type:

Theme:

Sharon Love1,Gavin Reilly1,Corran Roberts1,Adelyn Wise2,Paul Moayyedi3,Chris Foy4,Clive Stokes4,John De Caestecker5,Stephen Attwood6,Peter Watson7,Yeng Ang8,Pradeep Bhandiri9,Oliver Old4,Julie Hapeshi4,Ian Penman10,Colin Rodgers11,Cathryn Edwards12,David Monk13,Krish Ragunath14,Danielle Morris15,David Johnston16,Hugh Barr4,Janusz Jankowski17
1Centre for Statistics in Medicine (CSM), University of Oxford,2Oncology Clinical Trials Office, University of Oxford,3Department of Medicine, McMaster University Ontario, Canada,4Gloucester Royal Hospital, Gloucester, United Kingdom,5University Hospital Leicester, Leicester, United Kingdom,6School of Medicine, Pharmacy and Health, Durham University, Durham, United Kingdom,7Queens University Belfast,8Wrightington, Wigan & Leigh NHS, Wigan,9Spire Portsmouth Hospital, Portsmouth,,10Western General Hospital and Royal Infirmary Edinburgh, Edinburgh, United Kingdom,11Northern Trust, Antrim, United Kingdom,12South Devon Healthcare NHS Foundation Trust, Devon, United Kingdom,13Chester Hospital, Chester, United Kingdom,14Nottingham University Hospital, Nottingham, United Kingdom,15Queen Elizabeth II Hospital, Welwyn Garden City, United Kingdom,16Ninewells Hospital, Dundee, United Kingdom,17University Hospitals Coventry & Warwickshire NHS Trust, United Kingdom

Incorporating cancer risk information into general practice: a qualitative study using focus groups with healthcare professionals

Year:

Session type:

Theme:

Juliet Usher-Smith1,Barbora Silarova1,Alison Ward2,Jane Youell2,Kenneth Muir3,Jackie Campbell2,Joanne Warcaba4
1University of Cambridge,2University of Northampton,3University of Manchester,4Moulton Surgery, Northampton

Two-Year Efficacy and Safety Update: Phase III CheckMate 025 Study of Nivolumab vs Everolimus in Patients With Advanced Renal Cell Carcinoma (aRCC)

Year:

Session type:

Theme:

Elizabeth R. Plimack1,Robert J. Motzer2,Bernard Escudier3,Padmanee Sharma4,David F. McDermott5,Saby George6,Hans J. Hammers7,Michael Carducci7,Scott S. Tykodi8,Jeffrey A. Sosman9,Toni K. Choueiri10,Frede Donskov11,Howard Gurney12,Thomas C. Gauler13,Takeshi Ueda14,Huanyu Zhao15,Elmer Berghorn15,John Wagstaff16
1Fox Chase Cancer Center,2Memorial Sloan Kettering Cancer Center,3Gustave Roussy,4MD Anderson Cancer Center, University of Texas,5Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center,6Roswell Park Cancer Institute,7Johns Hopkins Sidney Kimmel Comprehensive Cancer Center,8University of Washington and Fred Hutchinson Cancer Research Center,9Vanderbilt University Medical Center,10Dana-Farber Cancer Institute/Brigham and Women’s Hospital,11Aarhus University Hospital,12Westmead Hospital and Macquarie University,13University Hospital Essen of University of Duisburg-Essen,14Chiba Cancer Center,15Bristol-Myers Squibb,16South West Wales Cancer Institute and Swansea University College of Medicine

Cervical cancer survival among women referred to cancer centres in Ghana

Year:

Session type:

Theme:

Yvonne Nartey1,Brian Cox1,Philip Hill1,Amo-Kwabena Antwi2
1University of Otago,2Komfo Anokye Teaching Hospital

Weekly cisplatin concurrent with IMRT does not increase risk of Lhermitte’s syndrome in head and neck cancer patients

Year:

Session type:

Theme:

Hannah Laidley1,David Noble2,Gill Barnett3,Raj Jena2,Neil Burnet2
1Cambridge University School of Clinical Medicine,2Cancer Research UK VoxTox Research Group, Department of Oncology, University of Cambridge,3Department of Oncology, Cambridge University Hospital's NHS Foundation Trust

Why do I choose to get screened? An examination of factors influencing participation in the Scottish Bowel Screening Programme

Year:

Session type:

Theme:

Kirsty Bisset1,Paul G Horgan1,Emilia M Crighton2,David Mansouri1
1Academic Unit of Surgery, School of Medicine - University of Glasgow,2Department of Public Health Screening Unit, NHS Greater Glasgow & Clyde

The development of GBM – A single case study

Year:

Session type:

Theme:

Astrid Wendler1,Sarah Field1,Juliane Perner1,Simon Tavaré1,Colin Watts1
1Cambridge University

Page 1 of 5711...25...Last »